Dual GLP-1 and GIP weight management peptide in self-mix vial format supplied with 2mL bacteriostatic water.

Product Overview

Tirzepatide 30mg Self Mix delivers dual GLP-1 and GIP receptor agonist support in traditional self-mix vial format for insulin syringe users. Supplied with 2mL bacteriostatic water for reconstitution.

Composition

Tirzepatide 30mg + 2mL bacteriostatic water

Strength & Volume

30mg | 1 x 30mg vial + 2mL bacteriostatic water

Dosing System

Insulin syringe dosing

Per Click/Unit

0.10mL = 1.5mg after 2mL reconstitution

Beginner Dose

10 units (1.5mg) Week 1

Standard Dose

50 units (7.5mg)

Max Dose

2 x 40 units (12mg)

Frequency

Once weekly (split twice weekly at higher doses)

Cycle Length & Off Period

Ongoing with escalation protocol | Off Period: N/A

Key Benefits

Triple-pathway fat loss | Appetite suppression | Satiety support | Self-mix format | Traditional dosing

Expected Outcomes

Reduced appetite / improved satiety / lower food intake / better calorie control / progressive fat loss.

Warnings

Not suitable under 18 / during pregnancy / while breastfeeding. Use bacteriostatic water. Do not shake aggressively. Always consult a healthcare professional.

Storage

Refrigerate at 2-8°C. Do not freeze.

Administration

Subcutaneous injection via insulin syringe. Once weekly.

Kit Contents

1 x Tirzepatide 30mg Vial + 2mL Bacteriostatic Water

Related Products

Bacteriostatic Water | Insulin Syringes | Tirzepatide 30mg | Retatrutide Self Mix